What is the share price of F D C Ltd (FDC) today?
The share price of FDC as on 30th April 2025 is ₹420.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on F D C Ltd (FDC) share?
The past returns of F D C Ltd (FDC) share are- Past 1 week: -0.93%
- Past 1 month: 8.09%
- Past 3 months: -11.71%
- Past 6 months: -19.10%
- Past 1 year: -8.74%
- Past 3 years: 56.60%
- Past 5 years: 68.13%
What are the peers or stocks similar to F D C Ltd (FDC)?
The peers or stocks similar to F D C Ltd (FDC) include:What is the market cap of F D C Ltd (FDC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of F D C Ltd (FDC) is ₹6858.37 Cr as of 30th April 2025.What is the 52 week high and low of F D C Ltd (FDC) share?
The 52-week high of F D C Ltd (FDC) is ₹658.85 and the 52-week low is ₹366.25.What is the PE and PB ratio of F D C Ltd (FDC) stock?
The P/E (price-to-earnings) ratio of F D C Ltd (FDC) is 22.47. The P/B (price-to-book) ratio is 3.27.Which sector does F D C Ltd (FDC) belong to?
F D C Ltd (FDC) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy F D C Ltd (FDC) shares?
You can directly buy F D C Ltd (FDC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
F D C Ltd
FDC Share Price
420.050.28% (-1.20)
FDC Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
FDC Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FDC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 24.99 | 3.27 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.81 | 6.38 | 0.53% |
FDC Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
FDC Company Profile
FDC Limited is a pharmaceutical company engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
FDC Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
45.24
1Y Return
18.66%
Buy Reco %
88.24
CIPLA
PE Ratio
30.21
1Y Return
9.48%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
67.89
1Y Return
23.64%
Buy Reco %
68.00
MANKIND
PE Ratio
55.15
1Y Return
7.57%
Buy Reco %
81.25
DRREDDY
PE Ratio
17.54
1Y Return
6.62%
Buy Reco %
46.67
FDC Forecasts
Price
Revenue
Earnings
FDC Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeFDC Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeFDC Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeFDC
Income
Balance Sheet
Cash Flow
Annual Normal View
FDC Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,032.86 | 1,064.15 | 1,126.03 | 1,134.17 | 1,413.09 | 1,430.24 | 1,604.01 | 1,833.61 | 2,044.57 | 2,180.50 | ||||||||||
Raw Materials | 363.25 | 340.29 | 354.77 | 367.29 | 420.53 | 440.17 | 595.64 | 670.93 | 709.63 | 1,758.51 | ||||||||||
| Power & Fuel Cost | 23.14 | 21.55 | 22.00 | 24.61 | 27.40 | 27.08 | 28.92 | 34.12 | 37.38 | |||||||||||
| Employee Cost | 175.76 | 191.08 | 216.67 | 225.57 | 277.48 | 296.29 | 343.33 | 390.90 | 413.40 | |||||||||||
| Selling & Administrative Expenses | 108.33 | 117.71 | 137.51 | 138.37 | 160.43 | 156.64 | 234.10 | 289.12 | 312.99 | |||||||||||
| Operating & Other expenses | 95.11 | 105.66 | 117.91 | 107.01 | 166.41 | 81.10 | 72.24 | 147.71 | 131.01 | |||||||||||
EBITDA | 267.27 | 287.86 | 277.17 | 271.32 | 360.84 | 428.96 | 329.78 | 300.83 | 440.16 | 421.99 | ||||||||||
| Depreciation/Amortization | 33.73 | 34.62 | 35.14 | 33.24 | 37.46 | 37.81 | 37.30 | 38.94 | 39.92 | 48.61 | ||||||||||
| PBIT | 233.54 | 253.24 | 242.03 | 238.08 | 323.38 | 391.15 | 292.48 | 261.89 | 400.24 | 373.38 | ||||||||||
| Interest & Other Items | 1.40 | 1.41 | 1.40 | 1.44 | 3.42 | 3.43 | 3.09 | 4.09 | 4.03 | 4.27 | ||||||||||
| PBT | 232.14 | 251.83 | 240.63 | 236.64 | 319.96 | 387.72 | 289.39 | 257.80 | 396.21 | 369.11 | ||||||||||
| Taxes & Other Items | 63.47 | 63.30 | 67.12 | 66.84 | 80.07 | 86.37 | 72.99 | 63.76 | 91.00 | 94.72 | ||||||||||
| Net Income | 168.67 | 188.53 | 173.51 | 169.80 | 239.89 | 301.35 | 216.40 | 194.04 | 305.21 | 274.39 | ||||||||||
| EPS | 9.32 | 10.42 | 9.68 | 9.56 | 13.77 | 17.74 | 12.82 | 11.59 | 18.57 | 16.85 | ||||||||||
| DPS | 2.25 | 2.25 | 0.00 | 0.00 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 | ||||||||||
| Payout ratio | 0.24 | 0.22 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 |
FDC Company Updates
FY 2015
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2024
Annual report
PDFFDC Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| F D C Ltd | 22.47 | 3.27 | — |
| Sun Pharmaceutical Industries Ltd | 45.24 | 6.46 | 0.75% |
| Cipla Ltd | 30.21 | 4.65 | 0.84% |
| Torrent Pharmaceuticals Ltd | 67.89 | 16.40 | 0.84% |
FDC Stock Price Comparison
Compare FDC with any stock or ETFCompare FDC with any stock or ETF
FDC
FDC Shareholdings
FDC Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
FDC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
FDC Shareholding Pattern
FDC Shareholding History
Foreign Institutions
Mutual Funds Invested in FDC
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding F D C Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4454% | Percentage of the fund’s portfolio invested in the stock 0.30% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 77/244 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9544% | Percentage of the fund’s portfolio invested in the stock 0.89% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/126 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6880% | Percentage of the fund’s portfolio invested in the stock 0.96% | Change in the portfolio weight of the stock over the last 3 months -0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/51 (-7) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing FDC stock
Looks like this stock is not in any smallcase yet.
FDC Events
FDC Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
FDC Upcoming Dividends
No upcoming dividends are available
FDC Past Dividends
Cash Dividend
Ex DateEx DateNov 22, 2024
Interim 1
Interim 1 | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Nov 22, 2024
Cash Dividend
Ex DateEx DateMar 19, 2020
Interim
Interim | Div/Share: ₹0.80
Dividend/Share
₹0.80
Ex DateEx Date
Mar 19, 2020
Cash Dividend
Ex DateEx DateAug 8, 2017
Final
Final | Div/Share: ₹2.25
Dividend/Share
₹2.25
Ex DateEx Date
Aug 8, 2017
Cash Dividend
Ex DateEx DateMar 17, 2016
Interim
Interim | Div/Share: ₹2.25
Dividend/Share
₹2.25
Ex DateEx Date
Mar 17, 2016
Cash Dividend
Ex DateEx DateSep 23, 2015
Final
Final | Div/Share: ₹2.25
Dividend/Share
₹2.25
Ex DateEx Date
Sep 23, 2015
FDC Stock News & Opinions
Articles & Videos
Earnings
FDC consolidated net profit declines 53.25% in the December 2024 quarter
Net profit of FDC declined 53.25% to Rs 37.04 crore in the quarter ended December 2024 as against Rs 79.23 crore during the previous quarter ended December 2023. Sales rose 1.30% to Rs 464.11 crore in the quarter ended December 2024 as against Rs 458.17 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales464.11458.17 1 OPM %10.0518.29 - PBDT64.53107.52 -40 PBT51.1897.55 -48 NP37.0479.23 -53 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
FDC to declare Quarterly Results
FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
FDC gets USFDA nod for anti-bacterial drug
The announcement was made at the fag end of market hours yesterday. Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections. The US drug regulator had conducted an inspection at the company's manufacturing facility located at Baddi, Himachal Pradesh, in the month of August 2024. On 13 November 2024, it had received the establishment inspection report (EIR) from USFDA with 'no observations' (Zero 483's). The inspection was carried out in relation to the ANDA-Cefuroxime Proxetil tablets and ANDA-Cefixime 400 mg tablets. FDC is engaged in the manufacturing and marketing of ORS (oral rehydration salts), anti-infectives, and ophthalmics. The company's consolidated net profit rose 3.2% to Rs 72.04 crore on 5.7% increase in net sales to Rs 513.85 crore in Q2 FY25 over Q2 FY24. The scrip added 0.66% to currently trade at Rs 517.95 on the BSE. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of FDC recommends first interim dividend
FDC announced that the Board of Directors of the Company at its meeting held on 6 November 2024, inter alia, have recommended the first interim dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
FDC consolidated net profit rises 3.18% in the September 2024 quarter
Net profit of FDC rose 3.18% to Rs 72.04 crore in the quarter ended September 2024 as against Rs 69.82 crore during the previous quarter ended September 2023. Sales rose 5.65% to Rs 513.85 crore in the quarter ended September 2024 as against Rs 486.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales513.85486.37 6 OPM %13.6515.71 - PBDT103.79102.60 1 PBT90.0092.73 -3 NP72.0469.82 3 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
FDC schedules board meeting
FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live
6 months agoCapital Market - Live
Spotlight
FDC Ltd leads gainers in 'A' group
Kaynes Technology India Ltd, Engineers India Ltd, Mrs Bectors Food Specialities Ltd and Varun Beverages Ltd are among the other gainers in the BSE's 'A' group today, 12 September 2024.FDC Ltd soared 10.82% to Rs 639.75 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 3.63 lakh shares were traded on the counter so far as against the average daily volumes of 30294 shares in the past one month. Kaynes Technology India Ltd spiked 6.79% to Rs 4976.3. The stock was the second biggest gainer in 'A' group. On the BSE, 18895 shares were traded on the counter so far as against the average daily volumes of 18212 shares in the past one month. Engineers India Ltd surged 5.87% to Rs 221.9. The stock was the third biggest gainer in 'A' group. On the BSE, 5.36 lakh shares were traded on the counter so far as against the average daily volumes of 3.5 lakh shares in the past one month. Mrs Bectors Food Specialities Ltd spurt 5.36% to Rs 1920. The stock was the fourth biggest gainer in 'A' group. On the BSE, 47524 shares were traded on the counter so far as against the average daily volumes of 18204 shares in the past one month. Varun Beverages Ltd exploded 5.14% to Rs 659.85. The stock was the fifth biggest gainer in 'A' group. On the BSE, 2.71 lakh shares were traded on the counter so far as against the average daily volumes of 1.26 lakh shares in the past one month. Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
FDC schedules AGM
FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
FDC to hold AGM
FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
FDC consolidated net profit rises 8.33% in the June 2024 quarter
Net profit of FDC rose 8.33% to Rs 119.04 crore in the quarter ended June 2024 as against Rs 109.89 crore during the previous quarter ended June 2023. Sales rose 19.00% to Rs 638.27 crore in the quarter ended June 2024 as against Rs 536.38 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales638.27536.38 19 OPM %22.9722.75 - PBDT173.76150.37 16 PBT162.73140.74 16 NP119.04109.89 8 Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.51%, vs industry avg of 9.04%
Over the last 5 years, market share increased from 0.52% to 0.54%
Over the last 5 years, net income has grown at a yearly rate of 12.44%, vs industry avg of 15.28%